← FDA DRUG APPROVALS

FDA ANDA · ANDA020167

ESTRADIOL

Sponsor: MYLAN PHARMS INC

APPLICATION
ANDA020167
TYPE
ANDA
ORIGINAL APPROVAL
2014-12-19
LATEST ACTION
2014-12-19
ROUTE
TRANSDERMAL
DOSAGE FORM
SYSTEM
MARKETING STATUS
Prescription

Products

ESTRADIOLPrescription
ESTRADIOL 0.1MG/DAY · SYSTEM · TRANSDERMAL
ESTRADIOLPrescription
ESTRADIOL 0.05MG/DAY · SYSTEM · TRANSDERMAL
ESTRADIOLPrescription
ESTRADIOL 0.025MG/DAY · SYSTEM · TRANSDERMAL
ESTRADIOLPrescription
ESTRADIOL 0.075MG/DAY · SYSTEM · TRANSDERMAL
ESTRADIOLPrescription
ESTRADIOL 0.0375MG/DAY · SYSTEM · TRANSDERMAL

Approval history

2014-12-19UNKNOWN · Original · unknown — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →